✦ LIBER ✦

IP/MS analysis of human CSF Aβ following a single dose of the C-terminal anti-Aβ antibody ponezumab (PF-04360365) to Alzheimer patients

✍ Scribed by Kathleen M. Wood; Frederick McCush; James J. Conboy; Robert Durham; Barbara Tate; Martin M. Bednar; Jaren W. Landen; Kieran F. Geoghegan; Kelly R. Bales

Book ID: 118465881
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 43 KB
Volume: 6
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2010.05.1015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of the anti-amyloid monoclonal an

Safety of the anti-amyloid monoclonal antibody ponezumab (PF-04360365) following a single-dose intravenous infusion in Japanese patients with mild-to-moderate Alzheimer's disease: Preliminary results

✍ Yoko Fujimoto; Izuru Miyoshi; Taro Ishibashi; Kanae Togo; Sadahiro Abe; James W. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Safety and Pharmacokinetics Following a

Safety and Pharmacokinetics Following a Single Infusion of the Anti-amyloid Monoclonal Antibody Ponezumab (pf-04360365) in Patients With Mild-to-moderate Alzheimer's Disease: Final Results

✍ Landen, Jaren W.; Zhao, Qinying; Cohen, Sharon; Borrie, Michael; Woodward, Micha 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Safety and pharmacokinetics following a

Safety and pharmacokinetics following a single 10-minute intravenous infusion of the anti-amyloid mAb ponezumab (PF-04360365) in patients with mild to moderate Alzheimer's disease

✍ Burstein, Aaron H.; Zhao, Qinying; Ross, Joel; Styren, Scot; Landen, Jaren W.; M 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Safety and pharmacokinetics of the anti-

Safety and pharmacokinetics of the anti-amyloid monoclonal antibody PF-04360365 following a single infusion in patients with mild-to-moderate Alzheimer's disease: Preliminary results

✍ Martin Bednar; Qinying Zhao; Jaren W. Landen; Clare B. Billing; Kevin Rohrbacher 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 96 KB